WPD Pharmaceuticals z
Biotechnology Research • 
Warsaw, Masovian Voivodeship, Poland • 11-20 Employees
Company overview
| Headquarters | Ochota, Mazowieckie 02-089, PL |
| Phone number | +48515262381 |
| Website | |
| NAICS | 541714 |
| Founded | 2017 |
| Employees | 11-20 |
| Socials |
Key Contact at WPD Pharmaceuticals z
Mariusz Olejniczak
Chief Executive Officer
WPD Pharmaceuticals z Email Formats
WPD Pharmaceuticals z uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@wpdpharmaceuticals.com), used 66.7% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@wpdpharmaceuticals.com | 66.7% |
{first initial}.{last name} | j.doe@wpdpharmaceuticals.com | 33.3% |
About WPD Pharmaceuticals z
WPD Pharmaceuticals is a Polish biotech company developing innovative oncology therapies for high-mortality cancers. While initially focused on lethal brain tumors like glioblastoma, WPD has built a diverse pipeline of patented drug candidates (licensed from Wake Forest University) including cutting-edge antibody-drug conjugates. Our flagship ADC, WPD401, co-developed with Wake Forest, uniquely targets four tumor-specific receptors (IL-13Rα2, EphA2, EphA3, EphB2) found in some of the toughest-to-treat cancers. Originally designed for glioblastoma, WPD401 has shown potent activity in other aggressive tumors that overexpress these receptors – for example, triple-negative breast, pancreatic, and certain lung cancers – thereby broadening its clinical potential into multiple high-need indications. Backed by this innovative multi-target approach and encouraging preclinical results, WPD is now advancing toward clinical trials in the United States. We are actively seeking strategic partners to co-develop and unlock the full potential of our pipeline, with the aim of delivering life-changing therapies for patients with limited treatment options. The controlling shareholder of WPD Poland is ACRX Investments Limited.
WPD Pharmaceuticals z revenue & valuation
| Annual revenue | $941,105 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $3,100,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
WPD Pharmaceuticals z has 5 employees across 4 departments.
Departments
Number of employees
Funding Data
WPD Pharmaceuticals z has never raised funding before.
WPD Pharmaceuticals z Tech Stack
Discover the technologies and tools that power WPD Pharmaceuticals z's digital infrastructure, from frameworks to analytics platforms.
Web servers
Security
JavaScript libraries
Tag managers
Security
Miscellaneous
Font scripts
Miscellaneous
Analytics
Israel
United States
Switzerland
Spain
United Kingdom
Frequently asked questions
4.8
40,000 users
